ALKS-33: Clinical Trials

2 trials of ALKS-33, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow ALKS-33: new trials by email Literature Review of ALKS-33 trials Research Report on ALKS-33

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
RDC-0313 (ALKS 33), Placebo - Binge Eating Disorder
Phase 2CompletedAlkermes, Inc.692010-05-012011-08-23
ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence
ALKS33 (RDC-0313) (1 mg), ALKS33 (RDC-0313) (2.5 mg), ALKS33 (RDC-0313) (10 mg) - Alcohol Dependence
Phase 2CompletedAlkermes, Inc.4062009-10-012011-08-23

Conditions studied

Alcoholism (1)  ·  Binge-Eating Disorder (1)

Sponsors

Alkermes, Inc. (2)

Countries

United States (2)

Results publications

PMID 23381803, PMID 30055046